Co-occurrence of mutations in and other susceptibility genes in pheochromocytoma and paraganglioma.

The percentage of patients diagnosed with pheochromocytoma and paraganglioma (altogether PPGL) carrying known germline mutations in one of the over fifteen susceptibility genes identified to date has dramatically increased during the last two decades, accounting for up to 35-40% of PPGL patients. Mo...

Full description

Bibliographic Details
Authors: Mellid, Sara, Gil, Eduardo, Letón, Rocío, Caleiras, Eduardo, Honrado, Emiliano, Richter, Susan, Palacios, Nuria, Lahera, Marcos, Galofré, Juan C, López-Fernández, Adriá, Calatayud, Maria, Herrera-Martínez, Aura D, Galvez, María A, Matias-Guiu, Xavier, Balbín, Milagros, Korpershoek, Esther, Lim, Eugénie S, Maletta, Francesca, Lider, Sofia, Fliedner, Stephanie M J, Bechmann, Nicole, Eisenhofer, Graeme, Canu, Letizia, Rapizzi, Elena, Bancos, Irina, Robledo Batanero, Mercedes, Cascon Soriano, Alberto
Format: article
Publication Date:2022
Country:España
Institution:Instituto de Salud Carlos III (ISCIII)
Repository:Repisalud
Language:English
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/26049
Online Access:https://hdl.handle.net/20.500.12105/26049
Access Level:Open access
Keyword:DLST
MDH2
NF1
co-occurrent mutations
germline mutation
pheochromocytoma
id ES_add78a40d60b60d0645545280bb7fdc2
oai_identifier_str oai:repisalud.isciii.es:20.500.12105/26049
network_acronym_str ES
network_name_str España
repository_id_str
spelling Co-occurrence of mutations in and other susceptibility genes in pheochromocytoma and paraganglioma.Mellid, SaraGil, EduardoLetón, RocíoCaleiras, EduardoHonrado, EmilianoRichter, SusanPalacios, NuriaLahera, MarcosGalofré, Juan CLópez-Fernández, AdriáCalatayud, MariaHerrera-Martínez, Aura DGalvez, María AMatias-Guiu, XavierBalbín, MilagrosKorpershoek, EstherLim, Eugénie SMaletta, FrancescaLider, SofiaFliedner, Stephanie M JBechmann, NicoleEisenhofer, GraemeCanu, LetiziaRapizzi, ElenaBancos, IrinaRobledo Batanero, MercedesCascon Soriano, AlbertoDLSTMDH2NF1co-occurrent mutationsgermline mutationpheochromocytomaThe percentage of patients diagnosed with pheochromocytoma and paraganglioma (altogether PPGL) carrying known germline mutations in one of the over fifteen susceptibility genes identified to date has dramatically increased during the last two decades, accounting for up to 35-40% of PPGL patients. Moreover, the application of NGS to the diagnosis of PPGL detects unexpected co-occurrences of pathogenic allelic variants in different susceptibility genes.FrontiersInstituto de Salud Carlos IIIEuropean Union (EU)MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES (ESPAÑA)20252025-01-1720222022-01-0120222022-01-01research articlehttp://purl.org/coar/resource_type/c_2df8fbb1VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.12105/26049reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)InglésengInstituto de Salud Carlos III http://dx.doi.org/10.13039/501100004587 Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII) PI18%2F00454 CARACTERIZACION MOLECULAR, OMICA Y FUNCIONAL DE MUTACIONES EN EL GEN DLST EN PACIENTES CON FEOCROMOCITOMA%2FPARAGANGLIOMAInstituto de Salud Carlos III http://dx.doi.org/10.13039/501100004587 Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII) PI20%2F01169 CARACTERIZACION DE NUEVAS ALTERACIONES MOLECULARES ASOCIADAS A DESARROLLO Y PROGRESION DE TUMORES RAROS ENDOCRINOS Y NEUROENDOCRINOS. MARCADORES PREDICTIVOS DE SENSIBILIDAD A TRATAMIENTO.open accesshttp://purl.org/coar/access_right/c_abf2Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/260492026-06-12T12:43:37Z
dc.title.none.fl_str_mv Co-occurrence of mutations in and other susceptibility genes in pheochromocytoma and paraganglioma.
title Co-occurrence of mutations in and other susceptibility genes in pheochromocytoma and paraganglioma.
spellingShingle Co-occurrence of mutations in and other susceptibility genes in pheochromocytoma and paraganglioma.
Mellid, Sara
DLST
MDH2
NF1
co-occurrent mutations
germline mutation
pheochromocytoma
title_short Co-occurrence of mutations in and other susceptibility genes in pheochromocytoma and paraganglioma.
title_full Co-occurrence of mutations in and other susceptibility genes in pheochromocytoma and paraganglioma.
title_fullStr Co-occurrence of mutations in and other susceptibility genes in pheochromocytoma and paraganglioma.
title_full_unstemmed Co-occurrence of mutations in and other susceptibility genes in pheochromocytoma and paraganglioma.
title_sort Co-occurrence of mutations in and other susceptibility genes in pheochromocytoma and paraganglioma.
dc.creator.none.fl_str_mv Mellid, Sara
Gil, Eduardo
Letón, Rocío
Caleiras, Eduardo
Honrado, Emiliano
Richter, Susan
Palacios, Nuria
Lahera, Marcos
Galofré, Juan C
López-Fernández, Adriá
Calatayud, Maria
Herrera-Martínez, Aura D
Galvez, María A
Matias-Guiu, Xavier
Balbín, Milagros
Korpershoek, Esther
Lim, Eugénie S
Maletta, Francesca
Lider, Sofia
Fliedner, Stephanie M J
Bechmann, Nicole
Eisenhofer, Graeme
Canu, Letizia
Rapizzi, Elena
Bancos, Irina
Robledo Batanero, Mercedes
Cascon Soriano, Alberto
author Mellid, Sara
author_facet Mellid, Sara
Gil, Eduardo
Letón, Rocío
Caleiras, Eduardo
Honrado, Emiliano
Richter, Susan
Palacios, Nuria
Lahera, Marcos
Galofré, Juan C
López-Fernández, Adriá
Calatayud, Maria
Herrera-Martínez, Aura D
Galvez, María A
Matias-Guiu, Xavier
Balbín, Milagros
Korpershoek, Esther
Lim, Eugénie S
Maletta, Francesca
Lider, Sofia
Fliedner, Stephanie M J
Bechmann, Nicole
Eisenhofer, Graeme
Canu, Letizia
Rapizzi, Elena
Bancos, Irina
Robledo Batanero, Mercedes
Cascon Soriano, Alberto
author_role author
author2 Gil, Eduardo
Letón, Rocío
Caleiras, Eduardo
Honrado, Emiliano
Richter, Susan
Palacios, Nuria
Lahera, Marcos
Galofré, Juan C
López-Fernández, Adriá
Calatayud, Maria
Herrera-Martínez, Aura D
Galvez, María A
Matias-Guiu, Xavier
Balbín, Milagros
Korpershoek, Esther
Lim, Eugénie S
Maletta, Francesca
Lider, Sofia
Fliedner, Stephanie M J
Bechmann, Nicole
Eisenhofer, Graeme
Canu, Letizia
Rapizzi, Elena
Bancos, Irina
Robledo Batanero, Mercedes
Cascon Soriano, Alberto
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Instituto de Salud Carlos III
European Union (EU)
MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES (ESPAÑA)

dc.subject.none.fl_str_mv DLST
MDH2
NF1
co-occurrent mutations
germline mutation
pheochromocytoma
topic DLST
MDH2
NF1
co-occurrent mutations
germline mutation
pheochromocytoma
description The percentage of patients diagnosed with pheochromocytoma and paraganglioma (altogether PPGL) carrying known germline mutations in one of the over fifteen susceptibility genes identified to date has dramatically increased during the last two decades, accounting for up to 35-40% of PPGL patients. Moreover, the application of NGS to the diagnosis of PPGL detects unexpected co-occurrences of pathogenic allelic variants in different susceptibility genes.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-01-01
2022
2022-01-01
2025
2025-01-17
dc.type.none.fl_str_mv research article
http://purl.org/coar/resource_type/c_2df8fbb1
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/20.500.12105/26049
url https://hdl.handle.net/20.500.12105/26049
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.relation.none.fl_str_mv Instituto de Salud Carlos III http://dx.doi.org/10.13039/501100004587 Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII) PI18%2F00454 CARACTERIZACION MOLECULAR, OMICA Y FUNCIONAL DE MUTACIONES EN EL GEN DLST EN PACIENTES CON FEOCROMOCITOMA%2FPARAGANGLIOMA
Instituto de Salud Carlos III http://dx.doi.org/10.13039/501100004587 Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII) PI20%2F01169 CARACTERIZACION DE NUEVAS ALTERACIONES MOLECULARES ASOCIADAS A DESARROLLO Y PROGRESION DE TUMORES RAROS ENDOCRINOS Y NEUROENDOCRINOS. MARCADORES PREDICTIVOS DE SENSIBILIDAD A TRATAMIENTO.
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Frontiers
publisher.none.fl_str_mv Frontiers
dc.source.none.fl_str_mv reponame:Repisalud
instname:Instituto de Salud Carlos III (ISCIII)
instname_str Instituto de Salud Carlos III (ISCIII)
reponame_str Repisalud
collection Repisalud
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869416492957696000
score 15.812429